2025³â 01¿ù 22ÀÏ ¼ö¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > ´º½ºÁö´åÄÄ > Science & Technology

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýÈ°

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óÇ°

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
- - - - - - -
 

Carbios and Novozymes Strengthen Collaboration With Long-Term Exclusive Strategic Partnership to Secure Worldwide Leadership in Biorecycling of PET

Exclusive agreement with Novozymes, world leader in enzyme production, ensures enzyme supply for Carbios¡¯ unique recycling technology at industrial scale for future Longlaville operations and all future licensee plants
´º½ºÀÏÀÚ: 2023-01-16

CLERMONT-FERRAND, FRANCE-- January 16, 2023 -- Regulatory News:

Carbios (Euronext Growth Paris: ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastics and textiles, and Novozymes, the world leader in biological solutions, announce today an exclusive long-term global strategic partnership. This major agreement ensures the long-term production and supply of Carbios’ proprietary PET-degrading enzymes at an industrial scale for the world’s first biological PET-recycling plant due to start production in 2025 in Longlaville (France), as well as Carbios’ future licensee customers.

Exclusive Global Partnership

Carbios and Novozymes have had a partnership since 2019 to develop enzyme-based solutions and address the sustainability challenge of plastic pollution, both within PET-recycling[1] and PLA-biodegradation[2]. Building on the current Joint Development Agreement (JDA), under the new agreement, Carbios and Novozymes will extend their collaboration to develop, optimize and produce enzymes that will subsequently be supplied by Novozymes to all licensees of Carbios’ technology. The new agreement grants both parties exclusivity in the field of the partnership.

Large-scale Industrial Deployment


The strategic partnership supports the large-scale industrial deployment of Carbios’ patented PET-recycling technology starting with Carbios’ future industrial reference unit in Longlaville (France), which will be the world’s first biological PET-recycling plant. Construction will begin later this year, and both building and operating permits having been filed with local authorities. Production at the plant is set to start in 2025 and the processing capacity will be 50,000 tonnes of waste per year.

“We are delighted to expand our partnership with Novozymes, the world leader in biological solutions, and to build on our strong existing relationship to provide a sustainable supply solution for our future customers,” commented Emmanuel Ladent, Chief Executive Officer of Carbios. “Novozymes’ continued support is testament to our joint commitment to achieve a truly circular economy for plastics and textiles that will benefit the environment and be economically viable for all business partners.”

“We are excited to advance our collaboration with Carbios by signing this exclusive agreement and to support the next phase of scaling this new business of biological plastic recycling,” said Hans Ole Klingenberg, Vice President, Marketing Agricultural & Industrial Biosolutions of Novozymes. “By providing biological solutions at a large scale, Novozymes is pleased to contribute in bringing Carbios’ biorecycling of PET-plastics and fibers to market.”



 Àüü´º½º¸ñ·ÏÀ¸·Î

Galderma Premieres Positive Interim Results Demonstrating the Efficacy of Its Injectable Aesthetics Portfolio
Bynder Showcases Its New and Expanded AI Capabilities at NRF to Help Retailers Drive Personalized Content Experiences
Quectel Unveils Ultra-Compact 5mm x 5mm x 1.05mm LS550G GNSS Module for Positioning in Low-Power Applications
FiRa Consortium Unveils FiRa Core 3.0 Specifications and Certification Program
LambdaTest Transforms Visual Testing with the Introduction of New Features in the SmartUI Visual AI Engine for Flawless Digital Experiences
Biocytogen Announces Licensing of Fully Human Antibodies with SOTIO
BOSTON ONCOLOGY ARABIA and SPIMACO Partner to Localize Advanced Oral Oncology Treatments in Saudi Arabia

 

Mesmerise to collaborate with Mayo Clinic to Transform Medical Educati...
Zepp Health to Showcase Groundbreaking Innovations at CES Pepcom & Sho...
Making Science launches RAISING, its new AI technology division to pow...
VeriSilicon¡¯s Display Processing IP DC8200-FS has Achieved ISO 26262 ...
Riskified and Appriss Retail Announce Pioneering Omnichannel Returns F...
Smart Communications Named a Leader in IDC MarketScape Reports for Int...
SPIE, the International Society for Optics and Photonics, Announces It...

 


°øÁö»çÇ×
´º½ºÁö ÇÑÀÚÇ¥±â 'ãæÚ¤ó¢'
´º½º±×·ì Á¤º¸ ¹Ìµð¾î ºÎ¹® »óÇ¥µî·Ï
¾ËÇÁ·Ò °è¿­ »óÇ¥, »óÇ¥µî·Ï ¿Ï·á
¾Ë¶ã°Ç¼³, »óÇ¥µî·Ï ¿Ï·á
Á¸Â÷´åÄÄ, ±Û²Ã º¯°æ »óÇ¥µî·Ï ¿Ï·á

 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æħ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇÑ°è¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, Æѽº 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..